A Retrospective Analysis of the Safety and Activity of Lutetium‐177‐Prostate‐Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration‐Resistant Prostate Cancer

BACKGROUND: Prostate cancer is a common malignancy of the elderly, and with the aging of the population, the need is growing for therapies suitable for this age group. Lutetium‐177–prostate‐specific membrane antigen (Lu‐PSMA), a radiolabeled small molecule, binds with high affinity to prostate‐speci...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Leibowitz, Raya, Davidson, Tima, Gadot, Moran, Aharon, Margalit, Malki, Avraham, Levartovsky, Meital, Oedegaard, Cecilie, Saad, Akram, Sandler, Israel, Ben‐Haim, Simona, Domachevsky, Liran, Berger, Raanan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2020
Gaiak:
Genitourinary Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485364/
https://ncbi.nlm.nih.gov/pubmed/32430954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0100
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak